Eton Pharmaceuticals Inc (ETON)
10.75
+0.32
(+3.07%)
USD |
NASDAQ |
Nov 21, 16:00
10.20
-0.55
(-5.12%)
Pre-Market: 08:34
Eton Pharmaceuticals Gross Profit Margin (Quarterly): 61.04% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 61.04% |
| June 30, 2024 | 62.00% |
| March 31, 2024 | 62.85% |
| December 31, 2023 | 49.64% |
| September 30, 2023 | 62.65% |
| June 30, 2023 | 80.70% |
| March 31, 2023 | 63.08% |
| December 31, 2022 | 74.84% |
| September 30, 2022 | 62.69% |
| June 30, 2022 | 62.69% |
| Date | Value |
|---|---|
| March 31, 2022 | 60.98% |
| December 31, 2021 | 93.89% |
| September 30, 2021 | 15.61% |
| June 30, 2021 | 94.33% |
| March 31, 2021 | 86.64% |
| December 31, 2020 | -455.6% |
| September 30, 2020 | 10.56% |
| June 30, 2020 | -40.00% |
| March 31, 2020 | -3.03% |
| December 31, 2019 | 1.31% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-455.6%
Minimum
Dec 2020
94.33%
Maximum
Jun 2021
25.35%
Average
62.33%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 74.73% |
| Integra Lifesciences Holdings Corp | 52.58% |
| Elutia Inc | 46.28% |
| Immuneering Corp | -- |
| Journey Medical Corp | 63.87% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -35.45% |
| Return on Assets | -16.95% |
| Return on Invested Capital | -26.81% |
| Profit Margin (Quarterly) | 6.07% |
| Operating Margin (Quarterly) | 4.93% |
| Return on Net Operating Assets | -47.15% |